BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37208267)

  • 1. [Ethambutol-induced toxic optic neuropathy during treatment of tuberculosis meningitis in a child].
    Krichene MA; Hassina S; Mrad K; Hasnaoui I; Serghini L; Abdallah E; Berraho HA
    J Fr Ophtalmol; 2023 Jun; 46(6):658-661. PubMed ID: 37208267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethambutol/Linezolid Toxic Optic Neuropathy.
    Libershteyn Y
    Optom Vis Sci; 2016 Feb; 93(2):211-7. PubMed ID: 26636399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe and reversible optic neuropathy by ethambutol and isoniazid].
    Rodríguez-Marco NA; Solanas-Alava S; Ascaso FJ; Martínez-Martínez L; Rubio-Obanos MT; Andonegui-Navarro J
    An Sist Sanit Navar; 2014; 37(2):287-91. PubMed ID: 25189987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular ethambutol toxicity.
    Melamud A; Kosmorsky GS; Lee MS
    Mayo Clin Proc; 2003 Nov; 78(11):1409-11. PubMed ID: 14601701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
    Zoumalan CI; Agarwal M; Sadun AA
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):410-6. PubMed ID: 15565293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rare ethambutol-induced optic neuropathy: A case-report and literature review.
    Song W; Si S
    Medicine (Baltimore); 2017 Jan; 96(2):e5889. PubMed ID: 28079833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea.
    Lee EJ; Kim SJ; Choung HK; Kim JH; Yu YS
    J Neuroophthalmol; 2008 Dec; 28(4):269-77. PubMed ID: 19145123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bitemporal hemianopia as presenting sign of severe ethambutol toxicity].
    Boulanger Scemama E; Touitou V; Le Hoang P
    J Fr Ophtalmol; 2013 Nov; 36(9):e163-7. PubMed ID: 24094504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethambutol-associated optic neuropathy.
    Lim SA
    Ann Acad Med Singap; 2006 Apr; 35(4):274-8. PubMed ID: 16710500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
    Kanaujia V; Jain VK; Sharma K; Agarwal R; Mishra P; Sharma RK
    Can J Ophthalmol; 2019 Jun; 54(3):301-305. PubMed ID: 31109468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural-functional dissociation in presumed ethambutol optic neuropathy.
    Masvidal D; Parrish RK; Lam BL
    J Neuroophthalmol; 2010 Dec; 30(4):305-10. PubMed ID: 20592624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethambutol and its ophthalmic effects; is screening and collaboration the new way forward?
    Vyas A; Subramanyam A; Phatak S; Tiwari S
    Indian J Tuberc; 2024 Jan; 71(1):30-34. PubMed ID: 38296388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethambutol induced toxic optic neuropathy - A retrospective study in a tertiary eye care centre in Southern India.
    Shanmugam MK; Sajja S; Kowsalya A; Balakrishnan HK; Jayasri KN
    Nepal J Ophthalmol; 2022 Jul; 14(28):108-115. PubMed ID: 37609972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ; Foroozan R
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.
    Saxena R; Singh D; Phuljhele S; Kalaiselvan V; Karna S; Gandhi R; Prakash A; Lodha R; Mohan A; Menon V; Garg R
    Indian J Ophthalmol; 2021 Dec; 69(12):3734-3739. PubMed ID: 34827033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.
    Saxena R; Phuljhele S; Prakash A; Lodha R; Singh D; Karna S; Mohan A; Gandhi R; Menon V; Garg R; The Inosrg
    J Assoc Physicians India; 2021 Feb; 69(2):54-57. PubMed ID: 33527812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual outcomes of toxic optic neuropathy secondary to Ethambutol: A retrospective observational study from India, an endemic country.
    Ambika S; Lakshmi KP; Gopal M; Noronha OV
    Indian J Ophthalmol; 2022 Sep; 70(9):3388-3392. PubMed ID: 36018127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.
    Matsumoto T; Kusabiraki R; Arisawa A; Fujiki T; Noda A; Tanaka A; Yamamoto N; Aihara K; Yamaoka S; Mishima M
    Intern Med; 2021 Jun; 60(11):1785-1788. PubMed ID: 33390493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy.
    Han J; Byun MK; Lee J; Han SY; Lee JB; Han SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2293-9. PubMed ID: 26344730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethambutol-induced optic neuropathy.
    Kyncl M; Fus M; Lestak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):288-293. PubMed ID: 35582729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.